These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 26175722

  • 1. MP-12 virus containing the clone 13 deletion in the NSs gene prevents lethal disease when administered after Rift Valley fever virus infection in hamsters.
    Gowen BB, Westover JB, Sefing EJ, Bailey KW, Nishiyama S, Wandersee L, Scharton D, Jung KH, Ikegami T.
    Front Microbiol; 2015; 6():651. PubMed ID: 26175722
    [Abstract] [Full Text] [Related]

  • 2. Using reverse genetics to manipulate the NSs gene of the Rift Valley fever virus MP-12 strain to improve vaccine safety and efficacy.
    Kalveram B, Lihoradova O, Indran SV, Ikegami T.
    J Vis Exp; 2011 Nov 01; (57):e3400. PubMed ID: 22083261
    [Abstract] [Full Text] [Related]

  • 3. Characterization of Rift Valley fever virus MP-12 strain encoding NSs of Punta Toro virus or sandfly fever Sicilian virus.
    Lihoradova OA, Indran SV, Kalveram B, Lokugamage N, Head JA, Gong B, Tigabu B, Juelich TL, Freiberg AN, Ikegami T.
    PLoS Negl Trop Dis; 2013 Nov 01; 7(4):e2181. PubMed ID: 23638202
    [Abstract] [Full Text] [Related]

  • 4. Post-exposure vaccination with MP-12 lacking NSs protects mice against lethal Rift Valley fever virus challenge.
    Gowen BB, Bailey KW, Scharton D, Vest Z, Westover JB, Skirpstunas R, Ikegami T.
    Antiviral Res; 2013 May 01; 98(2):135-43. PubMed ID: 23523764
    [Abstract] [Full Text] [Related]

  • 5. Attenuation of pathogenic Rift Valley fever virus strain through the chimeric S-segment encoding sandfly fever phlebovirus NSs or a dominant-negative PKR.
    Nishiyama S, Slack OA, Lokugamage N, Hill TE, Juelich TL, Zhang L, Smith JK, Perez D, Gong B, Freiberg AN, Ikegami T.
    Virulence; 2016 Nov 16; 7(8):871-881. PubMed ID: 27248570
    [Abstract] [Full Text] [Related]

  • 6. Rift Valley fever virus MP-12 vaccine encoding Toscana virus NSs retains neuroinvasiveness in mice.
    Indran SV, Lihoradova OA, Phoenix I, Lokugamage N, Kalveram B, Head JA, Tigabu B, Smith JK, Zhang L, Juelich TL, Gong B, Freiberg AN, Ikegami T.
    J Gen Virol; 2013 Jul 16; 94(Pt 7):1441-1450. PubMed ID: 23515022
    [Abstract] [Full Text] [Related]

  • 7. Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment.
    Scharton D, Bailey KW, Vest Z, Westover JB, Kumaki Y, Van Wettere A, Furuta Y, Gowen BB.
    Antiviral Res; 2014 Apr 16; 104():84-92. PubMed ID: 24486952
    [Abstract] [Full Text] [Related]

  • 8. Cytokine response in mouse bone marrow derived macrophages after infection with pathogenic and non-pathogenic Rift Valley fever virus.
    Roberts KK, Hill TE, Davis MN, Holbrook MR, Freiberg AN.
    J Gen Virol; 2015 Jul 16; 96(Pt 7):1651-1663. PubMed ID: 25759029
    [Abstract] [Full Text] [Related]

  • 9. Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments.
    Ikegami T, Hill TE, Smith JK, Zhang L, Juelich TL, Gong B, Slack OA, Ly HJ, Lokugamage N, Freiberg AN.
    J Virol; 2015 Jul 16; 89(14):7262-76. PubMed ID: 25948740
    [Abstract] [Full Text] [Related]

  • 10. Attenuation and protective efficacy of Rift Valley fever phlebovirus rMP12-GM50 strain.
    Ly HJ, Nishiyama S, Lokugamage N, Smith JK, Zhang L, Perez D, Juelich TL, Freiberg AN, Ikegami T.
    Vaccine; 2017 Dec 04; 35(48 Pt B):6634-6642. PubMed ID: 29061350
    [Abstract] [Full Text] [Related]

  • 11. A single-cycle replicable Rift Valley fever phlebovirus vaccine carrying a mutated NSs confers full protection from lethal challenge in mice.
    Terasaki K, Juelich TL, Smith JK, Kalveram B, Perez DD, Freiberg AN, Makino S.
    Sci Rep; 2018 Nov 20; 8(1):17097. PubMed ID: 30459418
    [Abstract] [Full Text] [Related]

  • 12. The dominant-negative inhibition of double-stranded RNA-dependent protein kinase PKR increases the efficacy of Rift Valley fever virus MP-12 vaccine.
    Lihoradova O, Kalveram B, Indran SV, Lokugamage N, Juelich TL, Hill TE, Tseng CT, Gong B, Fukushi S, Morikawa S, Freiberg AN, Ikegami T.
    J Virol; 2012 Jul 20; 86(14):7650-61. PubMed ID: 22573861
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of a recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheep.
    Weingartl HM, Nfon CK, Zhang S, Marszal P, Wilson WC, Morrill JC, Bettinger GE, Peters CJ.
    Vaccine; 2014 Apr 25; 32(20):2345-9. PubMed ID: 24462482
    [Abstract] [Full Text] [Related]

  • 14. Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain.
    Ly HJ, Lokugamage N, Nishiyama S, Ikegami T.
    PLoS One; 2017 Apr 25; 12(9):e0185194. PubMed ID: 28926632
    [Abstract] [Full Text] [Related]

  • 15. Estimation of the Minimal Rift Valley Fever Virus Protective Neutralizing Antibody Titer in Human Volunteers Immunized with MP-12 Vaccine Based on Protection in a Mouse Model of Disease.
    Watts DM, Westover JLB, Palermo PM, Bailey KW, Morrill JC, Bettinger GE, Monath TP, Smith DR, Peters CJ, Pittman PR, Orbegozo J, Gowen BB.
    Am J Trop Med Hyg; 2022 Nov 14; 107(5):1091-1098. PubMed ID: 36122681
    [Abstract] [Full Text] [Related]

  • 16. Identification and evaluation of antivirals for Rift Valley fever virus.
    Lang Y, Li Y, Jasperson D, Henningson J, Lee J, Ma J, Li Y, Duff M, Liu H, Bai D, McVey S, Richt JA, Ikegami T, Wilson WC, Ma W.
    Vet Microbiol; 2019 Mar 14; 230():110-116. PubMed ID: 30827375
    [Abstract] [Full Text] [Related]

  • 17. Rift Valley fever virus 78kDa envelope protein attenuates virus replication in macrophage-derived cell lines and viral virulence in mice.
    Terasaki K, Kalveram B, Johnson KN, Juelich T, Smith JK, Zhang L, Freiberg AN, Makino S.
    PLoS Negl Trop Dis; 2021 Sep 14; 15(9):e0009785. PubMed ID: 34516560
    [Abstract] [Full Text] [Related]

  • 18. Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene.
    Ikegami T, Won S, Peters CJ, Makino S.
    J Virol; 2006 Mar 14; 80(6):2933-40. PubMed ID: 16501102
    [Abstract] [Full Text] [Related]

  • 19. Countermeasure development for Rift Valley fever: deletion, modification or targeting of major virulence factor NSs.
    Lihoradova O, Ikegami T.
    Future Virol; 2014 Jan 01; 9(1):27-39. PubMed ID: 24910709
    [Abstract] [Full Text] [Related]

  • 20. Tilorone-Dihydrochloride Protects against Rift Valley Fever Virus Infection and Disease in the Mouse Model.
    Johnson KN, Kalveram B, Smith JK, Zhang L, Juelich T, Atkins C, Ikegami T, Freiberg AN.
    Microorganisms; 2021 Dec 31; 10(1):. PubMed ID: 35056541
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.